QNRX Quoin Pharmaceuticals, Ltd. - American Depositary Shares
$4,96
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 14, 2026
Rango 52S
$3–$42
4% of range
Calificación del Analista
BUY
10 analysts
Precio Objetivo
$21
+332% upside
P/E (TTM)
—
ROE
-201.7%
Margen de Beneficio Neto
—
QNRX Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$4.96
Capitalización Bursátil
$340M
P/E (TTM)
—
BPA (TTM)
—
Ingresos (TTM)
—
Rendimiento div.
—
ROE
-201.7%
Deuda/Capital
—
Rango 52S
$3 – $42
QNRX Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
BPA
—
Flujo de caja libre
—
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
QNRX
Mediana de Pares
P/B (P/C)
25.9
3.1
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
QNRX
Mediana de Pares
ROA
-87.6%
-64.2%
ROE
-201.7%
-102.0%
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
QNRX
Mediana de Pares
Current Ratio (Ratio corriente)
3.6
3.6
Quick Ratio (Ratio Rápido)
3.4
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
QNRX
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
QNRX
Mediana de Pares
QNRX Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
10 analistas
- Compra fuerte 2 20,0%
- Compra 7 70,0%
- Mantener 1 10,0%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
5 analistas · 2026-08-19
Mediana
$16.00
Media
$21.40
← Por Debajo de Todos los Objetivos
$4.96
Mín
$12.00
Máx
$35.00
Objetivo mediano
$16.00
+222,9%
Objetivo medio
$21.40
+331,9%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.93%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-1.77 | $-1.97 | 0.20% |
| 31 de diciembre de 2025 | $-1.50 | $-3.40 | 1.9% |
| 30 de septiembre de 2025 | $-6.71 | $-5.08 | -1.6% |
| 30 de junio de 2025 | $-6.28 | $-7.56 | 1.3% |
| 31 de marzo de 2025 | $-6.50 | $-6.19 | -0.31% |
| 31 de diciembre de 2024 | $-12.25 | $-16.42 | 4.2% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| QNRX | $757M | — | — | — | -201.7% | — |
| PLRZ | — | — | — | — | — | — |
| PLUR | $39M | -1.4 | 309.8% | -1690.3% | 669.5% | 48.9% |
| NRSN | — | — | — | — | — | — |
| CMMB | — | — | — | — | — | — |
| EVGN | — | — | — | — | — | — |
| CLGN | — | — | — | — | — | — |
| SLXN | — | 0.2 | — | — | — | — |
| URGN | $1.13B | — | 21.4% | -139.8% | 154.4% | 88.7% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $10M | $4M | $3M | $3M | $2M | |
| SG&A Expense | $6M | $6M | $6M | $7M | $4M | |
| Other Non-op | $486.1K | $566.0K | $691.9K | $-123.8K | $-15M | |
| Pretax Income | $-16M | $-9M | · | · | · | |
| Net Income | $-16M | $-9M | $-9M | $-9M | $-21M |
Balance general 19
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $4M | $2M | $3M | $7M | |
| Short-term Investments | $15M | $10M | · | · | · | |
| Prepaid Expense | $1M | $869.1K | $591.0K | $516.6K | $715.5K | |
| Current Assets | $20M | $15M | $11M | $13M | $8M | |
| Intangibles | $383.3K | $483.3K | $583.3K | $704.6K | $808.6K | |
| Total Assets | $20M | $16M | $12M | $14M | $9M | |
| Accounts Payable | $1M | $905.7K | $526.5K | $605.6K | $923.2K | |
| Accrued Liabilities | $3M | $2M | $1M | $1M | $2M | |
| Current Liabilities | $6M | $4M | $4M | $4M | $5M | |
| Other Non-current Liabilities | $2M | $2M | $3M | $4M | · | |
| Total Liabilities | $7M | $7M | $7M | $7M | $9M | |
| Common Stock | $0 | $0 | $0 | $0 | · | |
| Paid-in Capital | $84M | $64M | $52M | $48M | $32M | |
| Retained Earnings | $-71M | $-55M | $-46M | $-38M | $-28M | |
| Treasury Stock | · | · | · | $3M | $3M | |
| AOCI | $-613 | $55M | $46M | $38M | · | |
| Stockholders' Equity | $13M | $9M | $6M | $7M | $657.0K | |
| Liabilities + Equity | $20M | $16M | $12M | $14M | $9M | |
| Shares Outstanding | 52,441,360 | 8,948,164 | 987,220 | 403,887 | 55,913 |
Flujo de Efectivo 8
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $1M | $764.0K | · | |
| Amort. of Intangibles | $100.0K | $100.0K | $104.0K | $104.0K | $104.0K | |
| Operating Cash Flow | $-14M | $-8M | $-8M | $-8M | $-6M | |
| Investing Cash Flow | $-4M | $-2M | $2M | $-10M | $-625.0K | |
| Stock Issued | $19M | $12M | · | · | · | |
| Net Stock Activity | $19M | · | · | · | · | |
| Financing Cash Flow | $18M | $11M | $5M | $14M | $14M | |
| Net Change in Cash | $194.8K | $1M | · | · | · |
Rentabilidad 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -87.6% | -64.3% | -65.2% | -78.8% | · | |
| ROE | -201.7% | -122.4% | -132.8% | -113.2% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 3.6 | 3.2 | 3.8 | · | |
| Quick Ratio | 3.4 | 0.9 | 0.7 | 0.8 | · |
Valoración (TTM) 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-16M | $-9M | $-9M | $-9M | · | |
| Market Cap | $757M | $204M | $169M | $14.45T | · | |
| P/B | 57.7 | 22.1 | 29.9 | 1951264.6 | · | |
| P / Tangible Book | 59.4 | 23.4 | 33.4 | 2156388.6 | · | |
| P / Cash Flow | -55.9 | -25.9 | -21.6 | -1704166.1 | · |
Estado de resultados 4
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $4M | $3M | $3M | $2M | $2M | $2M | $1M | $1M | $587.5K | $885.3K | $832.4K | $758.8K | $625.1K | $1M | $613.1K | |
| SG&A Expense | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | |
| Other Non-op | $102.5K | $133.5K | $172.1K | $71.8K | $97.2K | $145.0K | $93.8K | $178.1K | $163.1K | $131.0K | $167.8K | $198.5K | $153.1K | $172.5K | $85.0K | |
| Net Income | $-5M | $-5M | $-4M | $-4M | $-4M | $-4M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-2M |
Balance general 19
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $3M | $4M | $2M | $2M | $4M | $4M | $3M | $3M | $2M | $2M | $3M | $5M | $3M | $3M | |
| Short-term Investments | $7M | $11M | $15M | · | · | · | $10M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $836.1K | $1M | $1M | $602.7K | $688.9K | $944.1K | $869.1K | $190.5K | $650.7K | $574.9K | $591.0K | $159.9K | $234.2K | $398.9K | $516.6K | |
| Current Assets | $12M | $15M | $20M | $6M | $8M | $12M | $15M | $10M | $13M | $15M | $11M | $14M | $16M | $17M | $13M | |
| Intangibles | $333.3K | $358.3K | $383.3K | $408.3K | $433.3K | $458.3K | $483.3K | $508.3K | $533.3K | $558.3K | $583.3K | $626.5K | $652.5K | $678.5K | $704.6K | |
| Total Assets | $12M | $16M | $20M | $6M | $9M | $13M | $16M | $11M | $14M | $16M | $12M | $15M | $17M | $18M | $14M | |
| Accounts Payable | $3M | $2M | $1M | $2M | $873.7K | $644.1K | $905.7K | $222.6K | $819.7K | $358.5K | $526.5K | $240.0K | $707.9K | $281.1K | $605.6K | |
| Accrued Liabilities | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $1M | $3M | $2M | $2M | $1M | |
| Current Liabilities | $7M | $5M | $6M | $6M | $4M | $5M | $4M | $3M | $4M | $4M | $4M | $5M | $4M | $4M | $4M | |
| Other Non-current Liabilities | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | · | $4M | |
| Total Liabilities | $8M | $7M | $7M | $8M | $6M | $7M | $7M | $6M | $7M | $7M | $7M | $8M | $8M | $8M | $7M | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $85M | $85M | $84M | $65M | $65M | $65M | $64M | $58M | $58M | $58M | $52M | $54M | $54M | $54M | $48M | |
| Retained Earnings | $-81M | $-76M | $-71M | $-67M | $-63M | $-59M | $-55M | $-53M | $-51M | $-49M | $-46M | $-44M | $-42M | $-40M | $-38M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | $3M | $3M | $3M | $3M | |
| AOCI | $-582 | $-159 | $-613 | · | $63M | $59M | · | $-53M | $50M | $48M | · | $44M | $42M | $40M | · | |
| Stockholders' Equity | $4M | $9M | $13M | $-1M | $3M | $6M | $9M | $5M | $7M | $9M | $6M | $7M | $9M | $11M | $7M | |
| Liabilities + Equity | $12M | $16M | $20M | $6M | $9M | $13M | $16M | $11M | $14M | $16M | $12M | $15M | $17M | $18M | $14M | |
| Shares Outstanding | 70,294,615 | 68,642,195 | 52,441,360 | 20,585,830 | 20,585,830 | 20,585,830 | 8,948,164 | 5,049,720 | 3,979,970 | 3,795,970 | 987,220 | 987,220 | 59,233,024,799 | 59,233,024,799 | 403,887 |
Flujo de Efectivo 6
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $533.0K | $444.5K | $283.2K | $182.2K | $321.5K | $360.4K | $326.3K | $313.1K | $313.1K | $306.3K | $300.2K | $268.5K | $264.4K | $261.5K | $267.3K | |
| Amort. of Intangibles | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $26.0K | $26.0K | $26.0K | $26.0K | $26.0K | |
| Operating Cash Flow | $-3M | $-5M | $-5M | $-2M | $-4M | $-3M | $-2M | $-2M | $-2M | $-1M | $-3M | $-1M | $-2M | $-2M | $-2M | |
| Investing Cash Flow | $4M | $4M | $-11M | $3M | $2M | $3M | $-3M | $3M | $3M | $-4M | $3M | $821 | $3M | $-3M | $0 | |
| Financing Cash Flow | $-151.9K | $56.0K | $18M | $-150.0K | $-150.0K | $23.0K | $6M | $-149.9K | $-136.3K | $5M | $-182.6K | $-275.0K | $-75.0K | $6M | $-446.9K | |
| Net Change in Cash | $721.1K | $-693.6K | · | · | $-2M | $198.8K | · | · | · | · | · | · | · | · | · |
Rentabilidad 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -51.4% | -34.9% | · | -44.3% | -32.2% | -26.2% | · | -41.3% | -13.6% | -13.5% | · | · | -25.2% | -28.2% | · | |
| ROE | -165.7% | -68.0% | · | -186.8% | -73.7% | -50.7% | · | -86.4% | -26.5% | -23.2% | · | · | -46.5% | -47.7% | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 2.9 | · | 1.0 | 2.0 | 2.6 | · | 3.0 | 3.3 | 3.6 | · | · | 3.6 | 4.2 | · | |
| Quick Ratio | 1.6 | 2.6 | · | 0.3 | 0.4 | 0.8 | · | 0.9 | 0.7 | 0.4 | · | · | 1.1 | 0.8 | · |
Valoración (TTM) 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-18M | $-16M | · | $-14M | $-12M | $-10M | · | $-9M | $-8M | $-9M | · | $-10M | $-10M | $-10M | · | |
| Market Cap | $340M | $453M | · | $148M | $190M | $161M | · | $87M | $81M | $126M | · | · | $12.44T | $11.84T | · | |
| P/B | 86.5 | 51.6 | · | -121.9 | 74.5 | 27.2 | · | 16.0 | 10.8 | 13.8 | · | · | 1371154.2 | 1084972.1 | · | |
| P / Tangible Book | 94.5 | 53.8 | · | · | 89.7 | 29.5 | · | 17.7 | 11.6 | 14.7 | · | · | 1477425.3 | 1156896.3 | · | |
| P / Cash Flow | · | -93.0 | · | · | · | -62.2 | · | · | · | -88.0 | · | · | · | -6780205.6 | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Beneficio neto | $-16M | $-9M | $-9M | $-9M | $-21M |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 3.6 | 3.6 | 3.2 | 3.8 | — |
| Ratio Rápido | 3.4 | 0.9 | 0.7 | 0.8 | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 19 declarantes · $6.0M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 1 (-5 vs trimestre anterior) | 3 (0 vs trimestre anterior) | 7 (0 vs trimestre anterior) | 5 (+1 vs trimestre anterior) | +58K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Dauntless Investment Group, LLC | $1 040 537 | 214 987 | 17,30% | Acciones |
| Ikarian Capital, LLC | $1 023 844 | 211 538 | 17,02% | Acciones |
| Stonepine Capital Management, LLC | $965 512 | 199 486 | 16,05% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $543 643 | 112 323 | 9,04% | Acciones |
| SummitTX Capital, L.P. | $485 452 | 100 300 | 8,07% | Acciones |
| Woodline Partners LP | $369 999 | 76 446 | 6,15% | Acciones |
| Aberdeen Group plc | $363 000 | 75 000 | 6,04% | Acciones |
| Soleus Capital Management, L.P. | $352 013 | 72 730 | 5,85% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $289 616 | 59 838 | 4,82% | Acciones |
| Velan Capital Investment Management LP | $156 680 | 32 372 | 2,61% | Acciones |
| BARCLAYS PLC | $103 910 | 21 469 | 1,73% | Acciones |
| Birchview Capital, LP | $96 800 | 20 000 | 1,61% | Acciones |
| AIGH Capital Management LLC | $91 960 | 19 000 | 1,53% | Acciones |
| XTX Topco Ltd | $72 629 | 15 006 | 1,21% | Acciones |
| MORGAN STANLEY | $38 720 | 8 000 | 0,64% | Acciones |
| RHUMBLINE ADVISERS | $11 280 | 2 332 | 0,19% | Acciones |
| UBS Group AG | $4 855 | 1 003 | 0,08% | Acciones |
| GAMMA Investing LLC | $2 125 | 439 | 0,04% | Acciones |
| SBI Securities Co., Ltd. | $1 718 | 355 | 0,03% | Acciones |
Informantes de la empresa 9 insiders · 4 directivos · 7 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Michael Myers | Chief Executive Officer | 4 de febrero de 2026 A | 602 808 | 0 | 0 | $0 |
| Sally Bridget Lawlor | Chief Financial Officer | 4 de febrero de 2026 A | — | 0 | 0 | $0 |
| Gordon Dunn | Chief Financial Officer | 23 de diciembre de 2024 P | 151 077 | 0 | 0 | $0 |
| Denise Carter | Chief Operating Officer | 4 de febrero de 2026 A | 602 648 | 0 | 0 | $0 |
| Natalie Ee Mun Leong | Consejero | 4 de febrero de 2026 A | — | 0 | 0 | $0 |
| Anthony James Culverwell | Consejero | 4 de febrero de 2026 A | 100 317 | 0 | 0 | $0 |
| Joseph Patrick Cooper | Consejero | 4 de febrero de 2026 A | — | 0 | 0 | $0 |
| Dennis Langer | Consejero | 4 de febrero de 2026 A | 15 153 | 1 | 0 | $128 640 |
| Michael T Sember | Consejero | 4 de febrero de 2026 A | — | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 3 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Michael Myers ×2 presentaciones | 28 de enero de 2025 | 0,00% | Enmienda | Inversión pasiva | SEC |
| Denise Carter ×2 presentaciones | 28 de enero de 2025 | 0,00% | Enmienda | Inversión pasiva | SEC |
| Dr. Shai Yarkoni ×3 presentaciones | 22 de abril de 2020 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.